Suppr超能文献

(5R)-5-羟基雷公藤内酯醇(LLDT-8)在 SIV 感染恒河猴中的治疗效果。

Therapeutic effect of (5R)-5-hydroxytriptolide (LLDT-8) in SIV infected rhesus monkeys.

机构信息

Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; Department of Infectious Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

出版信息

Int Immunopharmacol. 2022 Sep;110:108932. doi: 10.1016/j.intimp.2022.108932. Epub 2022 Jun 15.

Abstract

BACKGROUNDS

Human immunodeficiency virus (HIV) infections induce robust, generalized inflammatory responses and lead to pathological systemic immune activation. This abnormal immune status persists despite successful antiretroviral therapy (ART). Immune modulating strategies in conjunction with ART were tried to reduce abnormal immune activation. Previously, we demonstrated that Tripterygium Wilfordii Hook F has been shown immunosuppressive activity in HIV patients. (5R)-5-hydroxytriptolide (LLDT-8), a new analog of triptolide, and the most active ingredient of Tripterygium Wilfordii Hook F, has been shown to have lower cytotoxicity. However, the role of LLDT-8 in HIV or simian immunodeficiency virus (SIV) needs to be explored.

METHODS

Six male adult Chinese rhesus monkeys were enrolled in our study. All of them were healthy and negative for SIV, and chronically SIVmac239 infected macaques were treated with LLDT-8 combined with ART (n = 4) or ART only (n = 2) after 14 weeks of infection. ART was determined at week 33, and LLDT-8 was continued until week 48. T cell immune activation and inflammation were compared during the period, and viral rebound time and reservoir were supervised after stopping ART.

RESULTS

The RNA level of the two groups continued to decline after initiating ART, RNA of 4 rhesus monkeys declined to the lower limit of detection at week 20. LLDT-8 administration combined with ART did not affect T cell activation and plasma levels of IL-6 and CRP. The viral load of all the macaques in both groups was rebounded 2 weeks after ART discontinuation. Furthermore, no significant decrease of SIV DNA was observed in the LLDT-8 treatment group.

CONCLUSIONS

LLDT-8 administration during chronic SIV infection had no effect on T cell activation and plasma levels; Furthermore, LLDT-8 may not contribute to suppression of viral rebound and reservoir. These results suggest that LLDT-8 is unlikely to reduce immune activation and viral persistence without additional interventions.

摘要

背景

人类免疫缺陷病毒(HIV)感染会引起强烈的全身性炎症反应,并导致病理性的全身免疫激活。尽管接受了抗逆转录病毒治疗(ART),但这种异常的免疫状态仍然存在。人们尝试了免疫调节策略与 ART 联合使用,以降低异常的免疫激活。先前,我们已经证明雷公藤红素在 HIV 患者中具有免疫抑制活性。(5R)-5-羟基雷公藤内酯醇(LLDT-8),是雷公藤红素的一种新类似物,也是雷公藤红素的最有效成分,已显示出较低的细胞毒性。然而,LLDT-8 在 HIV 或猴免疫缺陷病毒(SIV)中的作用仍需进一步探索。

方法

本研究纳入了 6 只成年雄性中国猕猴。它们均健康且 SIV 阴性,慢性 SIVmac239 感染的猕猴在感染后 14 周接受 LLDT-8 联合 ART(n=4)或仅 ART(n=2)治疗。在第 33 周时确定 ART,LLDT-8 持续至第 48 周。在此期间比较了 T 细胞免疫激活和炎症情况,并在停止 ART 后监测病毒反弹时间和储存库。

结果

两组的 RNA 水平在开始 ART 后持续下降,4 只猕猴的 RNA 在第 20 周下降到检测下限。LLDT-8 联合 ART 治疗并不影响 T 细胞激活和血浆中 IL-6 和 CRP 的水平。两组所有猕猴的病毒载量在 ART 停药后 2 周均反弹。此外,在 LLDT-8 治疗组中未观察到 SIV DNA 显著减少。

结论

在慢性 SIV 感染期间给予 LLDT-8 治疗对 T 细胞激活和血浆水平没有影响;此外,LLDT-8 可能无助于抑制病毒反弹和储存库。这些结果表明,在没有其他干预措施的情况下,LLDT-8 不太可能降低免疫激活和病毒持续存在。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验